Meta-analysis of randomized trials comparing anti-embolic devices with standard PCI for improving myocardial reperfusion in patients with acute myocardial infarction

2007 ◽  
Vol 69 (4) ◽  
pp. 488-496 ◽  
Author(s):  
Babu Kunadian ◽  
Joel Dunning ◽  
Kunadian Vijayalakshmi ◽  
Andrew R. Thornley ◽  
Mark A. de Belder
Keyword(s):  
Myocardial Infarction ◽  
Acute Myocardial Infarction ◽  
Randomized Trials ◽  
Meta Analysis ◽  
Myocardial Reperfusion

Hypothermia in patients with acute myocardial infarction: a meta-analysis of randomized trials

2020 ◽  
Author(s):  
Brunilda Alushi ◽  
Gjin Ndrepepa ◽  
Alexander Lauten ◽  
Anna Lena Lahmann ◽  
Dario Bongiovanni ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Acute Myocardial Infarction ◽  
Randomized Trials ◽  
Meta Analysis

Long-term safety and efficacy of drug-eluting stents in patients with acute myocardial infarction: A meta-analysis of randomized trials

2011 ◽  
Vol 217 (1) ◽  
pp. 149-157 ◽  
Author(s):  
Raffaele Piccolo ◽  
Salvatore Cassese ◽  
Gennaro Galasso ◽  
Roberta De Rosa ◽  
Carolina D’Anna ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Acute Myocardial Infarction ◽  
Randomized Trials ◽  
Meta Analysis ◽  
Drug Eluting Stents ◽  
Safety And Efficacy ◽  
Drug Eluting

scholarly journals Carvedilol versus metoprolol succinate in the treatment of patients with heart failure with reduced ejection fraction and patients with acute myocardial infarction

2021 ◽  
Vol 2021 (1) ◽  
pp. 36-39
Author(s):  
E.Ya. Nikolenko ◽  
◽  
K.V. Vovk ◽  
O.L. Pavlova ◽  
O.O. Salun ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Heart Failure ◽  
Acute Myocardial Infarction ◽  
Ejection Fraction ◽  
Randomized Trials ◽  
Meta Analysis ◽  
Metoprolol Succinate ◽  
Reduced Ejection Fraction ◽  
Patients With Heart Failure ◽  
All Cause Mortality

Choosing the best drug for the treatment of cardiac patients remains one of the most important aspects of medical practice. The purpose of this review is to select the optimal beta-blocker for the treatment of patients with chronic heart failure and patients with acute myocardial infarction by comparing the efficacy of carvedilol and metoprolol succinate, as both drugs significantly reduce mortality rates and reduce hospitalization. The results of meta-analyzes, randomized trials comparing the efficacy of carvedilol and metoprolol succinate in the treatment of patients with heart failure with reduced ejection fraction and patients with acute myocardial infarction were analyzed. Conflicting data received. According to the study “Effect of carvedilol vs metoprolol succinate on mortality in heart failure with reduced ejection fraction”, a meta-analysis published in the American Journal of Cardiology in 2013, carvedilol is significantly more effective than metoprolol succinate in treatment of patients with heart failure with reduced ejection fraction and patients with acute myocardial infarction, while meta-analyzes of 2015 and 2017 showed no preference for carvedilol over metoprolol succinate. Based on the results, concluded that the data obtained is not sufficient to argue that carvedilol is more effective than metoprolol succinate for this category of patients in terms of reducing the risk of all-cause mortality, cardiovascular mortality, and reducing hospitalization. This problem requires further extensive research.

Sign in / Sign up

Export Citation Format

Share Document